Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Lead drug ZUNVEYL was FDA approved in July 2024 for Alzheimer's treatment. It is only...
— Mike Collins, Matt Clarke, Chase McIntosh, Carl Wiese
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Alpha Cognition Inc.
No other institutional pitches found for this ticker yet.
More institutional theses from GROW Funds
Management is confident in a $16 billion pipeline, up from $3 billion two years ago. Orion won a...
Top performer serving defense, space, and energy markets. Sells critical propulsion...
Strong performer throughout 2025. Positive operational improvements...